title: Prostaglandin production in the umbilical and uterine circulations in pregnant sheep at 129-136 days gestation.
abstract: Prostaglandins circulating in the maternal and foetal blood have been implicated in important physiological systems. These functions include foetal adrenal function, maintenance of patency of the ductus arteriosus, regulation of uterine and umbilical circulations, and labor and delivery type myometrial contractions. The placenta is a major site of prostaglandin production in pregnancy. Limited data are available which combine measurements of veno-arterial differences across the uterine and umbilical circulations with blood flow in these circulations to enable calculation of umbilical-placental and utero-placental production rates for the prostaglandins. In chronically instrumented pregnant ewes, between 129 and 136 days of gestation, prostaglandin F2 alpha(PGF2 alpha), 13, 14 dihydro-15-keto prostaglandin F2 alpha (PGFM), prostaglandin E2 (PGE2) were measured in the maternal carotid artery and uterine vein. Foetal PGE2, and 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha) (the major metabolite of prostacyclin) were measured in umbilical venous and foetal descending aorta arterial plasma. Umbilical and uterine blood flow were measured using the diffusion-equilibrium technique. Uterine blood flow was 1693 +/- 137 ml.min-1 (mean +/- SEM); uterine production rates were 480 +/- 88 ng.min-1 for PGF2 alpha, 517 +/- 144 ng.min-1 for PGFM, and 165 +/- 27 ng.min-1 for PGE2. Umbilical blood flow was 147 +/- 17 ml.min-1.kg-1 foetal body weight. Umbilical production rates into the foetal circulation were 11 +/- 2 ng.min-1.kg-1 for PGE2 and 6 +/- 2 ng. ng.min-1.kg-1 foetal body weight for PGI2.
authors.affiliation: Department of Physiology, NYS College of Veterinary Medicine, Cornell University, Ithaca.
authors.forename: A
authors.initials: A
authors.lastname: Kelleman
authors.forename: Z
authors.initials: Z
authors.lastname: Binienda
authors.forename: X Y
authors.initials: XY
authors.lastname: Ding
authors.forename: L
authors.initials: L
authors.lastname: Rittenhouse
authors.forename: M
authors.initials: M
authors.lastname: Mitchell
authors.forename: P W
authors.initials: PW
authors.lastname: Nathanielsz
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood*; D000818:Animals; D002339:Carotid Arteries; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000097:blood*; D015232:Dinoprostone / Q000097:blood*; D005260:Female; D005269:Femur; D005312:Fetal Blood; D005333:Fetus / Q000098:blood supply / Q000378:metabolism*; D005865:Gestational Age; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D014471:Umbilical Veins; D014599:Uterus / Q000098:blood supply / Q000378:metabolism*
chemical_list: C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D015121:6-Ketoprostaglandin F1 alpha; D015237:Dinoprost; D015232:Dinoprostone